133 related articles for article (PubMed ID: 21959298)
1. Flavonoids as vasorelaxant agents: synthesis, biological evaluation and quantitative structure activities relationship (QSAR) studies.
Dong X; Wang Y; Liu T; Wu P; Gao J; Xu J; Yang B; Hu Y
Molecules; 2011 Sep; 16(10):8257-72. PubMed ID: 21959298
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.
Dong X; Liu T; Yan J; Wu P; Chen J; Hu Y
Bioorg Med Chem; 2009 Jan; 17(2):716-26. PubMed ID: 19070497
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
Dong X; Chen J; Jiang C; Liu T; Hu Y
Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479
[TBL] [Abstract][Full Text] [Related]
4. Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
Dong X; Liu Y; Yan J; Jiang C; Chen J; Liu T; Hu Y
Bioorg Med Chem; 2008 Sep; 16(17):8151-60. PubMed ID: 18678502
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of flavonoids as vasorelaxant agents.
Chen Z; Hu Y; Wu H; Jiang H
Bioorg Med Chem Lett; 2004 Aug; 14(15):3949-52. PubMed ID: 15225704
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and neuroprotective agents.
Dong X; Qi L; Jiang C; Chen J; Wei E; Hu Y
Bioorg Med Chem Lett; 2009 Jun; 19(12):3196-8. PubMed ID: 19442520
[TBL] [Abstract][Full Text] [Related]
9. Structure and vasorelaxant activity of floranol, a flavonoid isolated from the roots of Dioclea grandiflora.
Lemos VS; Côrtes SF; dos Santos MH; Ellena J; Moreira ME; Doriguetto AC
Chem Biodivers; 2006 Jun; 3(6):635-45. PubMed ID: 17193297
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators.
Khalifa NM; Srour AM; Abd El-Karim SS; Saleh DO; Al-Omar MA
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072621
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and vasorelaxation action of flavonoids].
Chen ZW; Hu YZ; Wu HH; Jiang HD
Yao Xue Xue Bao; 2005 Nov; 40(11):1001-7. PubMed ID: 16499084
[TBL] [Abstract][Full Text] [Related]
12. Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
Torres-Piedra M; Figueroa M; Hernández-Abreu O; Ibarra-Barajas M; Navarrete-Vázquez G; Estrada-Soto S
Bioorg Med Chem; 2011 Jan; 19(1):542-6. PubMed ID: 21129983
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
14. Vasorelaxant effects of the extracts and some flavonoids from the buds of Coreopsis tinctoria.
Sun YH; Zhao J; Jin HT; Cao Y; Ming T; Zhang LL; Hu MY; Hamlati H; Pang SB; Ma XP
Pharm Biol; 2013 Sep; 51(9):1158-64. PubMed ID: 23763258
[TBL] [Abstract][Full Text] [Related]
15. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method.
Sivakumar PM; Geetha Babu SK; Mukesh D
Chem Pharm Bull (Tokyo); 2007 Jan; 55(1):44-9. PubMed ID: 17202700
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and vasorelaxant evaluation of novel coumarin-pyrimidine hybrids.
Amin KM; Awadalla FM; Eissa AA; Abou-Seri SM; Hassan GS
Bioorg Med Chem; 2011 Oct; 19(20):6087-97. PubMed ID: 21908192
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antiplatelet and vasorelaxing effects of monooxygenated flavones and flavonoxypropanolamines.
Chung MI; Han FW; Lin HC; Liou SS; Huang PL; Ko HH; Chang YL; Kang JJ; Teng CM; Lin CN
J Pharm Pharmacol; 2001 Dec; 53(12):1601-9. PubMed ID: 11804390
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and vasorelaxant evaluation of novel 7-methoxyl-2,3-disubstituted-quinoxaline derivatives.
Zheng CB; Gao WC; Pang PP; Ma X; Peng LC; Yang L; Li X
Bioorg Med Chem Lett; 2021 Mar; 36():127785. PubMed ID: 33444740
[TBL] [Abstract][Full Text] [Related]
19. Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.
Nofal ZM; Srour AM; El-Eraky WI; Saleh DO; Girgis AS
Eur J Med Chem; 2013 May; 63():14-21. PubMed ID: 23454530
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and vasodilator activity of some pyridazin-3(2
Allam HA; Kamel AA; El-Daly M; George RF
Future Med Chem; 2020 Jan; 12(1):37-50. PubMed ID: 31710239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
